EASIX-1year predicts NRM in patients surviving without disease progression for 1 year after allo-SCT. Kaplan-Maier curves for OS and cumulative incidences of NRM and TTR, according to EASIX quartiles calculated 1 year after allo-SCT in patients without relapse. (A) Training cohort. (B) Validation cohort. Q, quartile.